Rebus Holdings Inc (RBSH)

[Goodmooring]

A few things that make you question HOW this is a .007 sub penny stock..

1. Multiple Pharm prodrug Patents until 2034
2. Licensing agreements with another Pharm company worth 10's of millions 9/2018
3. Continued verifiable ongoing research in Denmark, Germany, and The USA. 2/2019
4. Military research involvement 11/2018
5. Samuel Denmeade, John Hopkins University School of Medicine, Sidney Kimmel Comprehensive Cancer Center, Department of Defense Prostate Cancer Research Program/Military Clinical Pipeline
6. Sabby Hedge fund, Hal Mintz - ownership investment 11/2018
7. JLL one of the world's leading investment managers, Connor Flannery - ownership investment 11/2018
8. Soren Christensen - University of Copenhagen - Continued research latest publication submitted in Dec 2018 Published in January 2019.
9. FDA - Orphan Drug Status for Mipsagargin
10. WHO’s International Nonproprietary Name group or the INN recommended the generic name “mipsagargin” for Inspyr's lead compound G-202

Going to take off with the impending SEC filings!!

$NSPX STRONGER